Patents by Inventor Kara L. Kopper

Kara L. Kopper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting the Reverse Mode of the Na+/Ca2+ Exchanger For the Treatment of Neurodegenerative Conditions
    Publication number: 20080161402
    Abstract: A method for treating a neurodegenerative condition, in an animal of the mammalian species, including humans, comprising the step of administering to ganglion cells and their axons (optic nerve) of said mammal a pharmaceutical composition which comprises as its active ingredient one or more compounds having activity for blocking a reverse mode of the sodium/calcium exchanger.
    Type: Application
    Filed: February 16, 2005
    Publication date: July 3, 2008
    Applicant: ALLERGAN, INC.
    Inventors: Joseph S. Adorante, George Ehring, Kara L. Kopper
  • Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy
    Patent number: 6479458
    Abstract: A method for preventing retinal ganglion cell depth, associated with glaucoma, in an animal of the mammalian species, including humans, comprising the step of administering to ganglion cells and their axons (optic nerve) of said mammal a pharmaceutical composition which comprises as its active ingredient one or more compounds having activity for blocking a reverse mode of the sodium/calcium exchanger.
    Type: Grant
    Filed: November 8, 2001
    Date of Patent: November 12, 2002
    Assignee: Allergan, Inc.
    Inventors: Joseph S. Adorante, George R. Ehring, Kara L. Kopper